Buprenorphine — 8MG, Tablet, bottle of 30 tablets

Buprenorphine — 8MG, Tablet, bottle of 30 tablets

Buprenorphine is a tablet for sublingual use. Buprenorphine Sublingual Tablets are indicated for the treatment of opioid dependence and are preferred for induction. Buprenorphine Sublingual Tablets should be used as part of a complete treatment plan to include counseling and psychosocial support.

• Active ingredient or product type: BUPRENORPHINE HYDROCHLORIDE
• Strength/concentration: 8MG
• Dosage form and route: Tablet, Sublingual
• Exact package presentation: bottle of 30 tablets
• NDC/item number: 0054-0177-13
• Manufacturer: HIKMA PHARMACEUTICALS USA INC
• Storage/handling: Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in USP. Store Buprenorphine Sublingual Tablets securely and dispose of properly [see Patient Counseling Information ( 17 )].
• Status: Rx only

Important safety information: • Addiction, Abuse, and Misuse : Buprenorphine can be abused in a similar manner to other opioids.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.